A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

Decipher genomic classifier scores combined with Gleason grade group improve risk stratification for prostate cancer patients on active surveillance. Patients with GG1 and high genomic classifier ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

When Sir Chris Hoy revealed that he had been diagnosed with stage-four prostate cancer in September 2023, aged just 47, the shockwaves reached far beyond the velodrome. Here was Britain’s most ...

More than 63,000 men are diagnosed with prostate cancer annually in the UK, with over 12,000 dying from the disease each year, according to Prostate Cancer UK. The prostate is a gland located next to ...

LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients ...

The Prostate Cancer Foundation (PCF) is proud to announce the launch of an interactive website and downloadable guide, Somatic and Germline Genetic Testing for Patients with Advanced Prostate ...

Prostate cancer is the most common cancer in men, affecting around one in eight in the UK – the equivalent of 52,000 new cases a year. However, despite its prevalence, if detected early, prostate ...

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI. You are ...